生命科学资讯

Big Pharma earnings kick off; Third-round IRA drugs selected; Hengrui’s trailblazing moment; and more

Did Strong 2025 Revenue Growth and 10x Genomics Deal Just Shift CareDx's (CDNA) Investment Narrative? - Yahoo Finance

AE Wealth Management LLC Has $9.54 Million Holdings in Agilent Technologies, Inc. $A - MarketBeat

Thermo Fisher Scientific (TMO) Valuation Check After Recent Share Price Pullback - simplywall.st

Chromatograph (Labor): Why Agilent’s Lab Chromatography Systems Are Quietly Powering the Most Impo - AD HOC NEWS

CRO Sygnature Discovery plans to send 60 UK staffers packing

Contract drug manufacturer Lonza forecasts slower sales growth for 2026 - MSN

Protein, please: Illumina buys protein startup in deal worth up to $425M - San Diego Union-Tribune

Thermo Fisher to close Mass. facility, lay off over 100 workers - The Business Journals

Boulder biotech SomaLogic acquired in deal worth up to $425M - The Business Journals

Corcept submitted lead asset for approval despite FDA flagging risk of ‘significant review issues’

FDA says it explained issues early on for Corcept's rejected Cushing's syndrome drug

Thermo Fisher Scientific (TMO): Analyst Ratings Update for Janua - GuruFocus

Illumina Completes Acquisition Of SomaLogic to Expand Proteomics And Multiomics Strategy - Pulse 2.0

Bitterroot reverts to preclinical biotech in CD47 as CEO leaves

CHMP opposes Lilly’s Mounjaro in heart failure, backs Novo’s Kayshild

Appointments and advancements for Jan. 30, 2026

Financings for Jan. 30, 2026

In the clinic for Jan. 30, 2026

Other news to note for Jan. 30, 2026